Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1387508 NEW YORK, NY

Position in AQST

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$211,874
+$78,999 QoQ
Shares Held
51,054
+148.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AQST Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in AQST

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $211,874 51,054
2025-12-31 $132,875 20,569
2025-09-30 $215,064 38,473
2025-06-30 $214,163 64,702
2025-03-31 $140,188 48,341
2024-12-31 $42,477 11,932
2024-09-30 $82,209 16,508
2024-06-30 $229,814 88,390
2024-03-31 $105,630 24,796